Jeongwon Yoon

Title: Jeongwon Yoon: Innovator in Antibody Development

Introduction

Jeongwon Yoon is a notable inventor based in Sejong-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. His work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Jeongwon Yoon holds a patent for an invention titled "Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof." This patent provides antibodies that specifically bind to human FAM19A5 and includes compositions comprising such antibodies. The antibodies are designed to be deimmunized to reduce immunogenicity in human subjects. In various embodiments, these anti-FAM19A5 antibodies can modulate FAM19A5 activity, potentially inhibiting or reversing the onset of reactive gliosis and excessive proliferation of reactive astrocytes. The patent also outlines methods for treating disorders such as central nervous system damage, degenerative brain disorders, neuropathic pain, or cancer by administering these specific antibodies.

Career Highlights

Throughout his career, Jeongwon Yoon has demonstrated a commitment to advancing medical science through his innovative research. His work has the potential to impact the treatment of various neurological conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Jeongwon Yoon collaborates with esteemed colleagues, including Bongcheol Kim and Wonkyum Kim. Their combined expertise contributes to the advancement of research and development in the field of antibody therapies.

Conclusion

Jeongwon Yoon is a prominent figure in the biotechnology sector, recognized for his innovative contributions to antibody development. His patent for anti-FAM19A5 antibodies represents a significant advancement in therapeutic options for various medical conditions.